Apelin receptor antagonist boosts dendritic cell vaccine efficacy in controlling angiogenic, metastatic and apoptotic-related factors in 4T1 breast tumor-bearing mice

[1]  A. Jafarzadeh,et al.  Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer. , 2022, Advances in medical sciences.

[2]  A. Czirók,et al.  Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis , 2021, Scientific Reports.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  S. Qiu,et al.  Interleukin 35 Activates Intratumor Neovascularization Via Enhanced Secretion of FGF2 in Hepatocellular Carcinoma Through The Recruitment of Neutrophils, and Blocking it Could Facilitate The Efficacy of The PD-1 Antibody , 2020 .

[5]  Q. Zhang,et al.  Regulation of Apelin Is Associated with Proliferation and Angiogenesis in Gastric Cancer , 2020 .

[6]  Zhaowu Ma,et al.  Dendritic cell biology and its role in tumor immunotherapy , 2020, Journal of Hematology & Oncology.

[7]  Ray Monk,et al.  Apelin Controls Angiogenesis-Dependent Glioblastoma Growth , 2020, International journal of molecular sciences.

[8]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[9]  K. Murphy,et al.  Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. , 2020, Cancer cell.

[10]  A. Jafarzadeh,et al.  Role of Apelin/APJ axis in cancer development and progression. , 2020, Advances in medical sciences.

[11]  A. Grumezescu,et al.  Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment , 2019, Journal of clinical medicine.

[12]  A. Dimberg,et al.  Tumor angiogenesis: causes, consequences, challenges and opportunities , 2019, Cellular and Molecular Life Sciences.

[13]  Shanyu Qin,et al.  Targeted blockade of interleukin 9 inhibits tumor growth in murine model of pancreatic cancer. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[14]  Yong Zhang,et al.  Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer. , 2019, International immunopharmacology.

[15]  J. Zuber,et al.  Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy , 2019, EMBO molecular medicine.

[16]  Yue Zhang,et al.  Effect of Th9/IL-9 on the growth of gastric cancer in nude mice , 2019, OncoTargets and therapy.

[17]  I. Castan-Laurell,et al.  The apelin/APJ system as a therapeutic target in metabolic diseases , 2019, Expert opinion on therapeutic targets.

[18]  W. Gerritsen,et al.  Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time , 2018, Front. Immunol..

[19]  Katarzyna Pietraszek-Gremplewicz,et al.  Apelin Effects Migration and Invasion Abilities of Colon Cancer Cells , 2018, Cells.

[20]  Dongfeng Guo,et al.  Apelin protects against sepsis‑induced cardiomyopathy by inhibiting the TLR4 and NLRP3 signaling pathways. , 2018, International journal of molecular medicine.

[21]  H. Antushevich,et al.  Review: Apelin in disease. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[22]  N. Bhardwaj,et al.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. , 2018, Trends in cancer.

[23]  R. Glen,et al.  Pharmacological targeting of apelin impairs glioblastoma growth , 2017, Brain : a journal of neurology.

[24]  L. Emens.  Breast Cancer Immunotherapy: Facts and Hopes , 2017, Clinical Cancer Research.

[25]  F. Ning,et al.  APJ Is Associated with Treatment Response in Gastric Cancer Patients Receiving Concurrent Chemoradiotherapy and Endostar Therapy. , 2017, Cancer biotherapy & radiopharmaceuticals.

[26]  S. Glaser,et al.  Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth. , 2017, Cancer letters.

[27]  Y. Maehara,et al.  The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma. , 2014, Anticancer research.

[28]  Chunhua Zhu,et al.  Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways , 2014, Neuroscience Letters.

[29]  H. Prats,et al.  Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas. , 2014, European journal of cancer.

[30]  Youmei Feng,et al.  Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis , 2013, The Journal of Immunology.

[31]  J. Tímár,et al.  Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  H. Xie,et al.  Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways , 2010, Amino Acids.

[33]  E. Ashley,et al.  Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. , 2009, American journal of physiology. Heart and circulatory physiology.

[34]  S. Fulda.  Tumor resistance to apoptosis , 2009, International journal of cancer.

[35]  S. Gonidec,et al.  Apelin is a potent activator of tumour neoangiogenesis , 2007, Oncogene.

[36]  K. Matsushima,et al.  Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer. , 2007, Cancer letters.

[37]  S. Murosaki,et al.  Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. , 1999, Biochimica et biophysica acta.

[38]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[39]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[40]  D. Ribnikar,et al.  Metastatic breast cancer. , 2014, Current opinion in oncology.